TriangleFOR PATIENTS · SOURCE READING
Metastatic Pheochromocytoma and Paraganglioma
Source: Pheochromocytoma and Paraganglioma Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 10, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
Context: Treatment of Pheochromocytoma and Paraganglioma
Treatment of metastatic pheochromocytoma or paraganglioma may include:
Source links and citations
Surgery to completely remove the cancer, including tumors that have spread to distant parts of the body.
Palliative therapy, to relieve symptoms and improve the quality of life, including:
Source links and citations
Palliative therapy, to relieve symptoms and improve the quality of life, including:
Surgery to remove as much cancer as possible.
Palliative therapy, to relieve symptoms and improve the quality of life, including:
Combination chemotherapy.
Source links and citations
Palliative therapy, to relieve symptoms and improve the quality of life, including:
Radiation therapy with 131I-MIBG.
Source links and citations
Palliative therapy, to relieve symptoms and improve the quality of life, including:
External radiation therapy to areas (such as bone) where cancer has spread and cannot be removed by surgery.
Source links and citations
Palliative therapy, to relieve symptoms and improve the quality of life, including:
Embolization (treatment to block an artery that supplies blood to a tumor).
Source links and citations
Palliative therapy, to relieve symptoms and improve the quality of life, including:
Ablation therapy using radiofrequency ablation or cryoablation for tumors in the liver or bone.
Source links and citations
Palliative therapy, to relieve symptoms and improve the quality of life, including:
Targeted therapy (tyrosine kinase inhibitors).
Source links and citations
Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.
Source links and citations
Preserved source evidence · Independent clinical review pending · Not medical advice